Subscribe to Paradeep Phosphates: Hem Securities

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Subscribe to Paradeep Phosphates: Hem Securities

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Subscribe to Paradeep Phosphates: Hem Securities

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Long Term Subscribe to Ethos: Hem Securities

Hem Securities has come out with its report on Ethos. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Ethos IPO: Offer subscribed 27% on Day 1, retail portion booked 53%

Ethos IPO: The company plans to garner Rs 472 crore through fresh issue of equity shares aggregating to Rs 375 crore and Rs 97.29 crore through the sale of 1,108,037 shares by the shareholders and promoters

Paradeep Phosphates IPO Day 2 highlights: Total subscription at 51%, retail portion booked 95%, NII 20%

Around 50 percent of the net offer will be reserved for QIBs, 35 percent for retail investors, and the remaining 15 percent for non-institutional investors.

Paradeep Phosphates IPO Day 1: Total subscription at 29%, retail portion booked 57%

The company aims to mop up Rs 1,501 crore by a combination of fresh issue of equity shares aggregating upto Rs 1,004 crore and an offer for sale (OFS) of 118,507,493 equity shares of Rs 10 each aggregating up to Rs 497.73 crore.

Avoid to Ethos: Choice Equity Broking

Choice Equity Broking has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 14, 2022.

Avoid to Ethos: Choice Equity Broking

Choice Equity Broking has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 14, 2022.

Avoid to Ethos: ICICI Direct

ICICI Direct has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 17, 2022.

Subscribe to Paradeep Phosphates: Choice Equity Broking

Choice Equity Broking has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 16, 2022.

Subscribe to Paradeep Phosphates: Geojit

Geojit has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 16, 2022.

Venus Pipes and Tubes IPO subscribed 16.31 times on final day, QIB portion booked 12.02 times

Qualified institutional buyers have, so far, subscribed only 36 percent of their quota of 10.14 lakh shares

Delhivery IPO Day 2 | Total subscription at 22%, retail portion booked 32%, employee quota 8%

The net fresh issue proceeds will be utilised for funding organic growth initiatives, and inorganic growth through acquisitions and other strategic initiatives, besides general corporate purposes.

Delhivery IPO Day 2 | Total subscription at 23%, retail portion booked 40%, employee quota 12%

The net fresh issue proceeds will be utilised for funding organic growth initiatives, and inorganic growth through acquisitions and other strategic initiatives, besides general corporate purposes.